SCHEMBL25499004

SCHEMBL25499004

FC(F)(F)c1cccc2c3ccncc3n(CCN3CCOCC3)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFATC1 O95644 1/20 0.43
GSK3B P49841 1/20 0.43
DYRK1A Q13627 1/20 0.43
CYP1A2 P05177 5/20 0.41
CYP2D6 P10635 5/20 0.41
CYP3A4 P08684 4/20 0.41
CYP2C19 P33261 3/20 0.41
HIF1A Q16665 2/20 0.41
LMNA P02545 2/20 0.41
USP2 O75604 3/20 0.40
HSD17B10 Q99714 2/20 0.39
ALOX15 P16050 2/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 3/20 0.39
POLB P06746 1/20 0.39
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
RECQL P46063 1/20 0.38
CNR1 P21554 1/20 0.38
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21711353 0.83 NFATC1 (0.43) NFATC1GSK3BDYRK1ACYP1A2CYP2D6
Hydrochloric Acid SCHEMBL21711340 0.82 NFATC1 (0.43) NFATC1GSK3BDYRK1ACYP1A2CYP2D6
Hydrochloric Acid SCHEMBL29423303 0.82 NFATC1 (0.43) NFATC1GSK3BDYRK1ACYP1A2CYP2D6
SCHEMBL25498997 0.80 USP2 (0.42) CYP1A2CYP2D6CYP3A4CYP2C19HIF1A
SCHEMBL26202615 0.77 DYRK1A (0.46) NFATC1GSK3BDYRK1ALMNA
SCHEMBL25499003 0.75 GAA (0.43) CYP1A2CYP2D6CYP3A4CYP2C19HIF1A
SCHEMBL16099686 0.75 NFATC1 (0.41) NFATC1GSK3BDYRK1ACYP1A2CYP2D6
SCHEMBL25498995 0.75 GAA (0.45) CYP1A2CYP2D6CYP3A4CYP2C19HIF1A
SCHEMBL21733496 0.74 CNR2 (0.44) GSK3BCYP2D6TSHRMAPK1CNR1
SCHEMBL25498999 0.72 GAA (0.45) CYP1A2CYP2D6CYP3A4LMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203036-A1 PYRROLO - DIPYRIDINE COMPOUNDS OSSIFI THERAPEUTICS LLC 2023-06-29 US disclosed
US-11655250-B2 Pyrrolo-dipyridine compounds OSTEOQC INC. (CA) 2023-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203036-A1 PYRROLO - DIPYRIDINE COMPOUNDS IMPDH1, DPYD, IGFBP5 NFATC1 1820/4885GSK3B 2479/4885DYRK1A 2323/4885
US-11655250-B2 Pyrrolo-dipyridine compounds IMPDH1, DPYD, IGFBP5 NFATC1 1820/4885GSK3B 2479/4885DYRK1A 2323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.